ISM8969

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

ZKH Group (NYSE: ZKH) posts first operating profit as GMV jumps 19%

Thunder Mountain Gold (TSXV: THM) closes C$8.1m South Mountain raise

eEnergy Group (AIM: EAAS) sinks 20% as £3.2m Mace payments slip

Nuclear Power Corporation of India is seeking plant-engineering and 3D-modelling support for the 220 MWe Bharat Small Reactor, advancing a nuclear power platform designed for captive deployment by India’s energy-intensive industries. Representative image.

Why NPCIL’s 220 MW Bharat Small Reactor needs a new 3D engineering platform

Insilico Medicine, Hygtia Therapeutics to advance AI-designed NLRP3 inhibitor for CNS diseases

Insilico and Hygtia partner to advance ISM8969, a brain-penetrant AI-designed NLRP3 inhibitor for CNS diseases. Find out what this means for the field.

μFR system
αvβ6-integrin
α4β7 integrin
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynyz
ZYNRELEF
Zynga

January 22, 2026